Ropinirole-d7 HCl

Ropinirole-d7 HCl, with the CAS number 1261396-31-9, is a highly specialized deuterated active pharmaceutical ingredient (API) that holds immense value for researchers and scientists in the field of pharmaceutical development. This compound, bearing the reference number 4Z-R-132, is a crucial tool in unlocking new frontiers in drug discovery and optimization.

As a deuterated version of the well-known dopamine agonist ropinirole, Ropinirole-d7 HCl offers a unique perspective for researchers. The strategic incorporation of deuterium atoms into the molecular structure can lead to enhanced metabolic stability, altered pharmacokinetic properties, and improved therapeutic efficacy. By leveraging the power of deuteration, scientists can explore novel drug candidates with the potential to address a wide range of neurological and other health conditions more effectively.

Exceptional Purity and Technical Specifications

Ropinirole-d7 HCl is meticulously crafted to meet the highest standards of purity and quality. With a molecular weight of 267.42 g/mol and a chemical formula of C16H17D7N2O·HCl, this compound presents as an off-white solid, ensuring its suitability for demanding research applications.

The detailed technical specifications of Ropinirole-d7 HCl provide researchers with the necessary information to optimize their experiments and unlock its full potential. Its unique properties, such as the presence of deuterium atoms and the hydrochloride salt form, contribute to its versatility and enable researchers to explore novel drug development strategies.

Diverse Applications in Pharmaceutical Research

Ropinirole-d7 HCl finds its primary application in the realm of pharmaceutical research, where it serves as a valuable tool for scientists exploring new therapeutic avenues. As a deuterated dopamine agonist, this compound can be utilized in the synthesis of innovative drug candidates targeting neurological disorders, such as Parkinson's disease, restless leg syndrome, and other conditions associated with dopaminergic dysfunction.

The strategic incorporation of deuterium atoms can lead to improved pharmacokinetic profiles, enhanced metabolic stability, and potentially reduced side effects compared to the non-deuterated counterpart. By leveraging the unique properties of Ropinirole-d7 HCl, researchers can develop more effective and safer drug formulations, ultimately benefiting patients and advancing the field of pharmaceutical science.

Handling and Storage Considerations

Ropinirole-d7 HCl is classified as a hazardous material, with potential health risks associated with ingestion, skin contact, and inhalation. Appropriate safety precautions must be taken when handling this compound, including the use of personal protective equipment (PPE) such as gloves, lab coats, and eye protection. Avoid breathing dust, fumes, gas, mist, vapors, or spray, and work in a well-ventilated area or outdoors.

For long-term storage, it is recommended to keep Ropinirole-d7 HCl refrigerated, as specified in the Certificate of Analysis. Ensure the container is tightly closed and stored in a dry, well-ventilated place to maintain the compound's stability and purity over time.

Unlocking the Potential of Ropinirole-d7 HCl

Ropinirole-d7 HCl is a powerful tool in the hands of researchers and scientists dedicated to advancing pharmaceutical development. By leveraging the unique properties of this deuterated compound, researchers can explore new frontiers in drug discovery, potentially leading to the creation of more effective and safer therapeutic options for patients.

To delve deeper into the technical details, applications, and safety guidelines of Ropinirole-d7 HCl, consult the relevant scientific literature, technical documents, and other resources provided by the manufacturer. These comprehensive materials will equip you with the knowledge and insights necessary to maximize the potential of this versatile compound in your research endeavors.